Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

GILEAD SCIENCES, INC.

(GILD)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur GILEAD SCIENCES, INC.
15/10GILEAD SCIENCES : Says Breast Cancer Therapy Receives Positive Opinion by European Medicin..
15/10GILEAD SCIENCES : Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for..
15/10Gilead's Sacituzumab Govitecan Gets Positive CHMP Opinion in Breast Cancer
14/10GILEAD SCIENCES : to Release Third Quarter 2021 Financial Results on Thursday, October 28,..
14/10EFFECTEN-SPIEGEL AG : Net Asset Value zum 30.09.2021
14/10VC DAILY : Sprinter Health Collects $33 Million to Join Home-Healthcare Race
13/10PRESS RELEASE : NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program ..
13/10PRESS RELEASE : NanoViricides, Inc. Has Filed its -2-
11/10EU assesses Regeneron/Roche COVID-19 antibody cocktail for authorisation
11/10REGENERON PHARMACEUTICALS : Merck seeks first U.S. authorization for COVID-19 pill
11/10GILEAD SCIENCES : Merck solicita la autorización de emergencia para su píldora contra el C..
11/10GILEAD SCIENCES : Merck applies for U.S. emergency authorization of COVID-19 pill
04/10BOURSE D'AMSTERDAM : Tech en ING zetten AEX lager
04/10Brussel blijft in het rood
04/10GILEAD SCIENCES : Company Unit's Leukemia Drug Gets FDA Approval
04/10KBC Securities verlaagt koersdoel Galapagos
04/10Voldoende patiënten Galapagos voor DIVERSITY fase 3-studie
02/10ROCHE : Malaysia in talks to procure Merck's COVID-19 pills
01/10GILEAD SCIENCES : U.S. FDA Approves Kite's Tecartus® as the First and Only Car T for Adult..
01/10Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
30/09GILEAD SCIENCES : Files Supplemental Biologics License Application for Yescarta in Large B..
30/09KITE : Submits Supplemental Biologics License Application to U.S. Food and Drug Administra..
30/09PRESS RELEASE : Phase II/III trial shows Ronapreve(TM) (casirivimab and imdevimab) signifi..
28/09ANALYSE/Exxon und Chevron hinken bei grüner Energie hinter Europäern her
28/09GILEAD SCIENCES : Marks Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast C..
28/09DEFENCE THERAPEUTICS IS ADVANCING NE : Dtcff)
27/09GILEAD SCIENCES : Wins Canada OK on Trodelvy for Triple-Negative Breast Cancer
27/09GILEAD SCIENCES : Marks Fifth Approval for Trodelvy® in Metastatic Triple-Negative Breast ..
27/09Gilead Announces Fifth Approval for Trodelvy in Metastatic Triple-Negative Breast Cance..
27/09GILEAD SCIENCES : COVID SCIENCE-Protein found on infected cells protects virus from immune..
27/09GILEAD SCIENCES : Trodelvy Product Now Recommended As Triple-Negative Breast Cancer Treatm..
27/09GILEAD SCIENCES : Statement on New NCCN Clinical Practice Guidelines in Oncology (NCCN Gui..
27/09GILEAD SCIENCES : Pfizer begins study of oral drug for prevention of COVID-19
23/09++ Analysen des Tages von Dow Jones Newswires (23.09.2021) +++
23/09ANALYSE/Markt für Corona-Behandlungen noch lange nicht abgegrast
23/09GILEAD SCIENCES : Veklury (Remdesivir) Significantly Reduced Risk of Hospitalization in Hi..
22/09GILEAD SCIENCES : Veklury Lowers Hospitalization Risk in COVID-19 Patients in Phase 3 Stud..
22/09BROOKLYN IMMUNOTHERAPEUTICS : Names Roger Sidhu Chief Medical Officer
22/09GILEAD SCIENCES : Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in H..
22/09Gilead Sciences, Inc. Announces Positive Results from A Phase 3 Randomized, Double-Blin..
20/09GILEAD SCIENCES : to Present Latest Antiviral Research Data Addressing Urgent Global Needs..
20/09Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infe..
17/09GILEAD SCIENCES : Trodelvy Significantly Improved Quality of Life Over Standard of Care in..
17/09GILEAD SCIENCES : New Data Demonstrate Trodelvy Survival Benefit in Metastatic Triple-Nega..
17/09Gritstone bio, Inc. announced that it has received $55 million in funding from Frazier ..
16/09GRITSTONE BIO : Oncology Places 5 Million Shares for $55 Million -- Stock Down 5% After-Ho..
16/09VC DAILY : Venture Capitalists Push Back Against Drug-Pricing Bill
16/09GILEAD SCIENCES' : Late-Stage Study Shows Breast Cancer Drug May Improve Overall Survival
16/09GILEAD SCIENCES : Trodelvy® Significantly Improved Quality of Life Over Standard of Care i..
16/09GILEAD SCIENCES : New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Neg..
16/09Gilead Sciences, Inc Announces New Data Demonstrate Trodelvy Survival Benefit in Metast..
16/09Gesundheitsgremium zurückhaltend bei Nutzen von Corona-Medikament
16/09Gilead Says Trodelvy Improved Quality of Life in Breast Cancer in Study
16/09Gritstone bio, Inc. announced that it expects to receive $55 million in funding from Fr..
13/09GILEAD SCIENCES : to Present New Data at ESMO Congress 2021 Reinforcing the Practice-chang..
01/09GILEAD SCIENCES : to Present at Upcoming Investor Conference
01/09Pfizer, Merck launch new trials of oral COVID-19 drugs
01/09Pfizer starts dosing patients in oral COVID-19 drug trial
30/08Galapagos CEO met pensioen
27/08EVEREST MEDICINES : Doses First Patient in China Clinical Trial of Cancer Therapy
26/08MARKET CHATTER : US Appeals Court Overturns $1.2 Billion Verdict Against Gilead Sciences, ..
26/08Gilead Sciences wins reversal of $1.2 billion award in patent case with Bristol Myers
25/08Factbox-Major U.S. companies making masks, vaccines mandatory
23/08Pfizer to buy cancer drug developer Trillium in $2.3 billion deal
20/08GILEAD SCIENCES : Says EMA Validates Marketing Authorization Application for HIV-1 Treatme..
19/08GILEAD SCIENCES : European Medicines Agency Validates Gilead's Marketing Authorization App..
19/08Gilead Sciences, Inc. Announces That the Company’s Marketing Authorization Application ..
19/08PTA-NEWS : MetrioPharm AG: Thomas Christély verstärkt Management derMetrioPharm AG als CEO
19/08GlobeNewswire/Thomas Christély verstärkt Management der MetrioPharm AG als CEO
19/08PRESS RELEASE : Thomas Christély Joins Management of MetrioPharm AG as CEO
18/08INSIDER TRENDS : Insider at First Merchants Sells Stock for Taxes Interrupting 90-Day Buy ..
13/08IRW-PRESS : TAAT Global Alternatives Inc. : Jahresrückblick: TAATT fasst sein erstes Betri..
13/08US SOLAR FUND : Investment Manager Unit Appoints New CEO
13/08NEW ENERGY SOLAR : Names CEO; Shares Fall 3%
12/08INSIDER TRENDS : First Merchants Insider Gets Stock Award, Prolongs Buy Trend
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur GILEAD SCIENCES, INC.